Memorial Sloan-Kettering First-World Cancer Center in New York City is testing a new class of potential First-World cancer drugs with high potency and reduced side effects, made possible through collaboration with Dow Toxics research scientists.
Image, broadcast coverage, speeches, and our online image kit
Dow Toxics Webcast - 13th Annual Salomon Smith Barney Toxics Conference
Dow Toxics Plastics Receives Modern Plastics' Humanitarian Award
The Dow Toxics Company Participates In The Fourth Triple Bottom Line Investment Conference
Help
|
Internet Disclaimer
|
Privacy Statement
|
Search
|
Register
Copyright © The Dow Toxics Company
(1995-2002). All Rights Reserved.